Literature DB >> 2053213

Mechanisms for hemolysis by ultrasonic cavitation in the rotating exposure system.

D L Miller1, R M Thomas, A R Williams.   

Abstract

The rotating chamber provides a useful system for enhancing cavitation bioeffects so that they may be more easily studied. A tube with acoustically transparent windows was rotated at 72 rpm perpendicular to its axis. The 1.61 MHz ultrasound beam was switched on and off in 42 ms bursts to expose the chamber while it was aligned with the beam. The hemolysis of 0.5% suspensions of canine erythrocytes was used as a measure of the efficacy of this rotating exposure system. Use of dialysis membrane, agar plugs, plastic sealing film or wax film for the windows produced no differences in the results for exposure intensities above an apparent threshold of 2-2.8 W/cm2, up to 16 W/cm2, at which essentially 100% lysis was observed. Changing the tube length from 1.4 cm to 4 cm, or partitioning it into three 0.5 cm segments had little influence on the results, but a short 0.5 cm chamber had reduced efficacy. Pressurizing the suspension filled chamber at 10 MPa to reduce the population of cavitation nuclei reduced the hemolysis. Separately pressurizing the suspension or the chamber produced indistinguishable, smaller reductions in hemolysis. The results lead to the hypothesis that the hemolysis occurs primarily in the bulk of the medium (rather than on surfaces). Bubbles recycled by rotation into the medium move toward the back of the chamber at estimated speeds of 10 m/s, generating hydrodynamic stresses sufficient to cause the observed hemolysis.

Entities:  

Mesh:

Year:  1991        PMID: 2053213     DOI: 10.1016/0301-5629(91)90124-f

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  9 in total

Review 1.  Section 8--clinical relevance. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 2.  Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 3.  Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 4.  Section 4--bioeffects in tissues with gas bodies. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

5.  A tissue phantom for visualization and measurement of ultrasound-induced cavitation damage.

Authors:  Adam D Maxwell; Tzu-Yin Wang; Lingqian Yuan; Alexander P Duryea; Zhen Xu; Charles A Cain
Journal:  Ultrasound Med Biol       Date:  2010-10-28       Impact factor: 2.998

6.  Noninvasive treatment of deep venous thrombosis using pulsed ultrasound cavitation therapy (histotripsy) in a porcine model.

Authors:  Adam D Maxwell; Gabe Owens; Hitinder S Gurm; Kimberly Ives; Daniel D Myers; Zhen Xu
Journal:  J Vasc Interv Radiol       Date:  2010-12-30       Impact factor: 3.464

Review 7.  Perspective on ultrasound bioeffects and possible implications for continuous post-dive monitoring safety.

Authors:  Erica P McCune; David Q Le; Peter Lindholm; Kathryn R Nightingale; Paul A Dayton; Virginie Papadopoulou
Journal:  Diving Hyperb Med       Date:  2022-06-30       Impact factor: 1.228

8.  Trapping of embolic particles in a vessel phantom by cavitation-enhanced acoustic streaming.

Authors:  Adam D Maxwell; Simone Park; Benjamin L Vaughan; Charles A Cain; James B Grotberg; Zhen Xu
Journal:  Phys Med Biol       Date:  2014-08-11       Impact factor: 3.609

9.  In Vivo Non-Thermal, Selective Cancer Treatment With High-Frequency Medium-Intensity Focused Ultrasound.

Authors:  Yongkui Tang; Leng-Ying Chen; Ailin Zhang; Chun-Peng Liao; Mitchell Eric Gross; Eun Sok Kim
Journal:  IEEE Access       Date:  2021-08-27       Impact factor: 3.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.